HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells

[1]  B. Korber,et al.  Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E , 2016, Science.

[2]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..

[3]  T. Ottenhoff,et al.  Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA‐E during active tuberculosis and express type 2 cytokines , 2015, European journal of immunology.

[4]  T. Ottenhoff,et al.  Human CD8+ T-cells Recognizing Peptides from Mycobacterium tuberculosis (Mtb) Presented by HLA-E Have an Unorthodox Th2-like, Multifunctional, Mtb Inhibitory Phenotype and Represent a Novel Human T-cell Subset , 2015, PLoS pathogens.

[5]  M. Strong,et al.  HspX vaccination and role in virulence in the guinea pig model of tuberculosis. , 2014, Pathogens and disease.

[6]  D. Lewinsohn,et al.  Human Lung Epithelial Cells Contain Mycobacterium tuberculosis in a Late Endosomal Vacuole and Are Efficiently Recognized by CD8+ T Cells , 2014, PloS one.

[7]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[8]  J. Posey,et al.  O-mannosylation of the Mycobacterium tuberculosis Adhesin Apa Is Crucial for T Cell Antigenicity during Infection but Is Expendable for Protection , 2013, PLoS pathogens.

[9]  O. Burlet-Schiltz,et al.  Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis , 2013, Proceedings of the National Academy of Sciences.

[10]  E. Adams,et al.  The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. , 2013, Annual review of immunology.

[11]  Malcolm J. McConville,et al.  MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.

[12]  Desmond S. Lun,et al.  Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant, rpoB Mutant Mycobacterium tuberculosis , 2012, Journal of bacteriology.

[13]  Michael J. MacCoss,et al.  Platform-independent and Label-free Quantitation of Proteomic Data Using MS1 Extracted Ion Chromatograms in Skyline , 2012, Molecular & Cellular Proteomics.

[14]  J. Posey,et al.  Cellular Immune Responses to Nine Mycobacterium tuberculosis Vaccine Candidates following Intranasal Vaccination , 2011, PloS one.

[15]  Nicole A. Kruh,et al.  Proteomic Definition of the Cell Wall of Mycobacterium tuberculosis , 2010, Journal of proteome research.

[16]  Matthew S. Cook,et al.  Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells , 2010, PLoS biology.

[17]  Darren R. Flower,et al.  Mycobacterium tuberculosis Peptides Presented by HLA-E Molecules Are Targets for Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity , 2010, PLoS pathogens.

[18]  William R. Jacobs,et al.  A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis , 2009, PLoS pathogens.

[19]  G. Hatfull,et al.  Recombineering in Mycobacterium tuberculosis , 2007, Nature Methods.

[20]  J. Belisle,et al.  Export-Mediated Assembly of Mycobacterial Glycoproteins Parallels Eukaryotic Pathways , 2005, Science.

[21]  M. Fernandez-Vina,et al.  Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine1 , 2004, The Journal of Immunology.

[22]  E. Bradbury,et al.  Comprehensive Proteomic Profiling of the Membrane Constituents of a Mycobacterium tuberculosis Strain*S , 2003, Molecular & Cellular Proteomics.

[23]  M. Alderson,et al.  Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. , 2003, American journal of respiratory and critical care medicine.

[24]  V. K. Chadda,et al.  The Apa Protein of Mycobacterium tuberculosis Stimulates Gamma Interferon-Secreting CD4+ and CD8+ T Cells from Purified Protein Derivative-Positive Individuals and Affords Protection in a Guinea Pig Model , 2003, Infection and Immunity.

[25]  J. Belisle,et al.  HLA-E–dependent Presentation of Mtb-derived Antigen to Human CD8+ T Cells , 2002, The Journal of experimental medicine.

[26]  C. Willberg,et al.  Human T cell receptor‐mediated recognition of HLA‐E , 2002, European journal of immunology.

[27]  S. Anfossi,et al.  The analysis of the natural killer‐like activity of human cytolytic T lymphocytes revealed HLA‐E as a novel target for TCR α/β‐mediated recognition , 2001 .

[28]  S. Reed,et al.  Classically Restricted Human CD8+ T Lymphocytes Derived from Mycobacterium tuberculosis-Infected Cells: Definition of Antigenic Specificity1 , 2001, The Journal of Immunology.

[29]  P. Andersen,et al.  Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells , 2000, European journal of immunology.

[30]  S. Reed,et al.  Mycobacterium tuberculosis-Reactive CD8+ T Lymphocytes: The Relative Contribution of Classical Versus Nonclassical HLA Restriction1 , 2000, The Journal of Immunology.

[31]  G. Besra,et al.  CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection , 2000, Nature.

[32]  O. Bârzu,et al.  Decreased Capacity of Recombinant 45/47-kDa Molecules (Apa) ofMycobacterium tuberculosis to Stimulate T Lymphocyte Responses Related to Changes in Their Mannosylation Pattern* , 1999, The Journal of Biological Chemistry.

[33]  O. Bârzu,et al.  Deglycosylation of the 45/47-Kilodalton Antigen Complex of Mycobacterium tuberculosis Decreases Its Capacity To Elicit In Vivo or In Vitro Cellular Immune Responses , 1999, Infection and Immunity.

[34]  T. Elliott,et al.  Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules in Vivo , 1999, The Journal of experimental medicine.

[35]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[36]  J. Coligan,et al.  Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. , 1999, Journal of immunology.

[37]  E. Grant,et al.  CD1-Restricted Microbial Lipid Antigen-Specific Recognition Found in the CD8+ αβ T Cell Pool , 1999, The Journal of Immunology.

[38]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[40]  M. Meldal,et al.  T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. , 1997, Cancer research.

[41]  J. Herrmann,et al.  Bacterial glycoproteins: a link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. , 1996, The EMBO journal.

[42]  K. Khoo,et al.  Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis , 1996, Journal of bacteriology.

[43]  K. Khoo,et al.  Evidence for glycosylation sites on the 45-kilodalton glycoprotein of Mycobacterium tuberculosis , 1995, Infection and immunity.

[44]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[45]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[46]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[47]  J. Flynn,et al.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  H. Wiker,et al.  Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis , 1991, Infection and immunity.

[49]  J. Belisle,et al.  N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC. , 2009, Glycobiology.

[50]  S. Anfossi,et al.  The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. , 2001, European journal of immunology.

[51]  E. Grant,et al.  CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. , 1999, Journal of immunology.

[52]  C. Horn,et al.  Characterization of murine monoclonal antibodies specific for the 45/47 kDa antigen complex (APA) of Mycobacterium tuberculosis, M. bovis and BCG. , 1996, Journal of immunological methods.

[53]  P Parham,et al.  Structure, function, and diversity of class I major histocompatibility complex molecules. , 1990, Annual review of biochemistry.

[54]  C. Espitia,et al.  Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens. , 1989, Clinical and experimental immunology.